Drugs and Drug Candidates

Drugs and Drug Candidates is an international, peer-reviewed, open access journal on drug discovery, development, and knowledge, published quarterly online by MDPI.
  • Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
  • Rapid Publication: manuscripts are peer-reviewed and a first decision is provided to authors approximately 22.4 days after submission; acceptance to publication is undertaken in 6.6 days (median values for papers published in this journal in the second half of 2023).
  • Recognition of Reviewers: APC discount vouchers, optional signed peer review, and reviewer names published annually in the journal.
  • Drugs and Drug Candidates is a companion journal of Pharmaceuticals.
Add your e-mail address to receive forthcoming issues of this journal:
Special Issue in DDC
Fighting SARS-CoV-2 and Related Viruses Guest Editors: Jean Jacques Vanden Eynde, Annie Mayence
Deadline: 30 June 2024
Special Issue in DDC
Drugs of the Kallikrein-Kinin System Guest Editor: François Marceau
Deadline: 31 December 2024
Topical Collection in DDC
Bioinorganic Chemistry in Drug Discovery Collection Editors: Tanja Soldatović, Snežana Jovanović-Stević
Topical Collection in DDC
Chirality in Drugs and Drug Candidates Collection Editors: Carla Fernandes, Maria Emília De Sousa
Topical Collection in DDC
Anti-Parasite Drug Discovery Collection Editor: Philippe Loiseau
Back to TopTop